(Q61938359)

English

Tolerability of Rebif® (Interferon-beta 1-A) Therapy in Korean Patients With Multiple Sclerosis

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A Prospective, Multi-center, Observational Study to Assess the Tolerability of Interferon-beta 1-A (Rebif®) Therapy for Korean Patients With Multiple Sclerosis (English)

0 references

0 references

0 references

August 2008

0 references

end time

November 2011

0 references

number of participants

60

0 references

research intervention

interferon beta-1a

0 references

research site

Samsung Medical Center

0 references

research subject recruitment status

completed

0 references

study type

observational study

0 references

Identifiers

ClinicalTrials.gov ID

NCT01074346

0 references

(Q61938359)

Tolerability of Rebif® (Interferon-beta 1-A) Therapy in Korean Patients With Multiple Sclerosis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)